CIVI BIOPHARMA Trademark

Trademark Overview

On Friday, February 16, 2018, a trademark application was filed for CIVI BIOPHARMA with the United States Patent and Trademark Office. The USPTO has given the CIVI BIOPHARMA trademark a serial number of 87982795. The federal status of this trademark filing is REGISTERED as of Tuesday, April 21, 2020. This trademark is owned by CiVi Biopharma, Inc.. The CIVI BIOPHARMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, metabolic and autoimmune diseases and related disorders
civi biopharma

General Information

Serial Number87982795
Word MarkCIVI BIOPHARMA
Filing DateFriday, February 16, 2018
Status700 - REGISTERED
Status DateTuesday, April 21, 2020
Registration Number6037774
Registration DateTuesday, April 21, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 25, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, metabolic and autoimmune diseases and related disorders
NOT AVAILABLE"BIOPHARMA"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, February 24, 2018
Primary Code005
First Use Anywhere DateMonday, November 18, 2019
First Use In Commerce DateMonday, November 18, 2019

Trademark Owner History

Party NameCiVi Biopharma, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressChevy Chase, MD 20815
Party NameCiVi Biopharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBryn Mawr, PA 19010
Party NameCiVi Biopharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBryn Mawr, PA 19010

Trademark Events

Event DateEvent Description
Friday, June 1, 2018ASSIGNED TO EXAMINER
Tuesday, February 20, 2018NEW APPLICATION ENTERED
Saturday, February 24, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 5, 2018NON-FINAL ACTION WRITTEN
Tuesday, June 5, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 5, 2018NON-FINAL ACTION E-MAILED
Monday, July 9, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 23, 2018ASSIGNED TO LIE
Tuesday, July 24, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 24, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 21, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 5, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 25, 2018PUBLISHED FOR OPPOSITION
Tuesday, September 25, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 20, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, February 25, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, February 25, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 17, 2019SOU TEAS EXTENSION RECEIVED
Friday, May 17, 2019SOU EXTENSION 1 FILED
Friday, May 17, 2019SOU EXTENSION 1 GRANTED
Wednesday, November 20, 2019SOU EXTENSION 2 FILED
Tuesday, May 21, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 20, 2019SOU TEAS EXTENSION RECEIVED
Wednesday, November 20, 2019SOU EXTENSION 2 GRANTED
Friday, November 22, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 29, 2020TEAS STATEMENT OF USE RECEIVED
Wednesday, January 29, 2020TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, January 29, 2020DIVISIONAL REQUEST RECEIVED
Monday, March 2, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 2, 2020STATEMENT OF USE PROCESSING COMPLETE
Wednesday, March 18, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, March 19, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 21, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, March 9, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 29, 2020USE AMENDMENT FILED
Monday, March 2, 2020DIVISIONAL PROCESSING COMPLETE
Tuesday, March 9, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 9, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 9, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 21, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, March 9, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Related Keywords

biopharma civi diseases related disorders autoimmune metabolic preparations treatment cardiovascular pharmaceutical